PT2062053E - Métodos de imunoensaio melhorados - Google Patents

Métodos de imunoensaio melhorados

Info

Publication number
PT2062053E
PT2062053E PT78042769T PT07804276T PT2062053E PT 2062053 E PT2062053 E PT 2062053E PT 78042769 T PT78042769 T PT 78042769T PT 07804276 T PT07804276 T PT 07804276T PT 2062053 E PT2062053 E PT 2062053E
Authority
PT
Portugal
Prior art keywords
immunoassay methods
improved immunoassay
improved
methods
immunoassay
Prior art date
Application number
PT78042769T
Other languages
English (en)
Inventor
Tony Barnes
Andrea Murray
John Forsyth Russell Robertson
Caroline Chapman
Original Assignee
Oncimmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncimmune Ltd filed Critical Oncimmune Ltd
Publication of PT2062053E publication Critical patent/PT2062053E/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
PT78042769T 2006-09-13 2007-09-12 Métodos de imunoensaio melhorados PT2062053E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84415806P 2006-09-13 2006-09-13
GB0618055A GB2441824A (en) 2006-09-13 2006-09-13 Immunoassay method

Publications (1)

Publication Number Publication Date
PT2062053E true PT2062053E (pt) 2013-02-11

Family

ID=37309880

Family Applications (2)

Application Number Title Priority Date Filing Date
PT111831889T PT2444812E (pt) 2006-09-13 2007-09-12 Métodos de imunoensaio melhorados
PT78042769T PT2062053E (pt) 2006-09-13 2007-09-12 Métodos de imunoensaio melhorados

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT111831889T PT2444812E (pt) 2006-09-13 2007-09-12 Métodos de imunoensaio melhorados

Country Status (9)

Country Link
EP (1) EP2444812B1 (pt)
CN (1) CN103257227B (pt)
BR (1) BRPI0716720A2 (pt)
DK (2) DK2062053T3 (pt)
ES (2) ES2556360T3 (pt)
GB (1) GB2441824A (pt)
PT (2) PT2444812E (pt)
SG (1) SG174803A1 (pt)
SI (1) SI2062053T1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6453299B2 (ja) * 2013-03-15 2019-01-16 エグザゲン ダイアグノスティクス，インコーポレイテッド 全身性エリテマトーデスを治療および診断するための方法
CN103969453B (zh) * 2014-05-30 2016-07-06 苏州工业园区为真生物医药科技有限公司 甲胎蛋白自身抗体单独或与甲胎蛋白联合作为肿瘤诊断、疗效评估和复发监控标志物的应用
CN111413498B (zh) * 2020-04-08 2023-08-04 复旦大学附属中山医院 一种肝细胞肝癌的自身抗体7-AAb检测panel及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810040D0 (en) * 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
AUPP349098A0 (en) 1998-05-13 1998-06-04 South Eastern Sydney Area Health Service A method of monitoring pancreatic tissue viability
GB2395270B (en) * 2002-11-14 2006-08-16 Univ Nottingham Tumour marker proteins and uses thereof
CN1525170A (zh) * 2003-09-15 2004-09-01 南京农业大学 检测猪繁殖与呼吸综合征抗体的elisa试剂盒及用法
CN1766620A (zh) * 2005-10-13 2006-05-03 南京农业大学 检测猪日本脑炎抗体的重组e蛋白elisa试剂盒
CN1804629A (zh) * 2005-12-01 2006-07-19 南京农业大学 检测猪圆环病毒2型抗体的试剂盒
CN101632020B (zh) * 2006-09-13 2013-11-27 昂西免疫有限公司 改进的免疫测定方法

Also Published As

Publication number Publication date
BRPI0716720A2 (pt) 2013-09-03
EP2444812A2 (en) 2012-04-25
SI2062053T1 (sl) 2013-03-29
GB2441824A (en) 2008-03-19
CN103257227A (zh) 2013-08-21
EP2444812B1 (en) 2015-12-02
CN103257227B (zh) 2015-12-02
ES2397979T3 (es) 2013-03-12
GB0618055D0 (en) 2006-10-25
DK2444812T3 (en) 2016-01-11
ES2556360T3 (es) 2016-01-15
EP2444812A3 (en) 2012-05-09
DK2062053T3 (da) 2013-03-04
PT2444812E (pt) 2016-03-11
SG174803A1 (en) 2011-10-28

Similar Documents

Publication Publication Date Title
HK1131210A1 (en) Improved immunoassay methods
IL194892A0 (en) Nonseparation assay methods
GB0615662D0 (en) Antibody
EP2021778A4 (en) DOSING METHODS WITHOUT SEPARATION
EP2011869A4 (en) NEW ANTI-CD98 ANTIBODY
IL196268A0 (en) Assay methods
GB0613209D0 (en) Methods
GB0600967D0 (en) Methods
EP2015785A4 (en) ANTIGEN AGRM2
GB0608941D0 (en) Methods
IL215528A0 (en) Improved immunoassay methods
SI2062053T1 (sl) Izboljšani imunotestni postopki
EP2115136A4 (en) NOVEL PROCEDURE
GB0607377D0 (en) Novel Methods
GB0720672D0 (en) Assay method
GB0606276D0 (en) Antibodies
GB0607376D0 (en) Antibodies
ZA200709879B (en) Improved immunoassay methods
GB0606198D0 (en) Methods
GB0618704D0 (en) Methods
GB0614313D0 (en) Methods
GB0606432D0 (en) Methods
GB0618836D0 (en) Methods
GB0624391D0 (en) Methods
GB0616140D0 (en) Methods